Federal Register: January 11, 2007 (Volume 72, Number 7)
DOCID: fr11ja07-59 FR Doc 07-77
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
NOTICE: NOTICES
DOCID: fr11ja07-59
ACTION: Meetings:
SUBJECT CATEGORY:
National Institute on Drug Abuse; Notice of Closed Meeting
DOCUMENT SUMMARY:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Technical Support for Constituency Outreach and Research Dissemination.
Date: February 1, 2007.
Time: 9:30 a.m. to 11:30 p.m.
Agenda: To review and evaluate contract proposals. [[Page 1339]]
Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892 8401, (301) 4351439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of Health, HHS)
Dated: January 3, 2007.
Anna M. Snouffer,
Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 0777 Filed 11007; 8:45 am]
BILLING CODE 414001M
SUMMARY:
National Institute on Drug Abuse,
DOCUMENT BODY 2:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Technical Support for Constituency Outreach and Research Dissemination.
Date: February 1, 2007.
Time: 9:30 a.m. to 11:30 p.m.
Agenda: To review and evaluate contract proposals. [[Page 1339]]
Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892 8401, (301) 4351439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of Health, HHS)
Dated: January 3, 2007.
Anna M. Snouffer,
Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 0777 Filed 11007; 8:45 am]
BILLING CODE 414001M